Email Updates

You are here

Webinar & Meeting Reports

  • February 26, 2014

    This webinar kicked off our year-long dialogue about prevention research and advocacy, Research & Reality. We’ve designed the series to provide information and debate about key topics. Some of these are clear priorities, while others will undoubtedly emerge as data and country-level progress take us in new directions.

  • December 10, 2013

    Hosted jointly by NAM and AVAC, the last webinar for 2013 in our series addressed a range of topics in HIV prevention research, including the development of the EATG/NAM community consensus statement on treatment as prevention, a set of principles intended to guide policy on access to antiretroviral therapy for prevention purposes for people with HIV, to be launched in January.

  • December 9, 2013

    The final webinar of the Fall series discussed what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use.

  • November 3, 2013 to November 5, 2013

    This inaugural translational medicine conference: What Will it Take to Achieve an AIDS-Free World?, which will bring the audiences and editors of The Lancet and Cell together to bridge the gap between clinicians and researchers focused on understanding, managing, preventing and curing HIV/AIDS.

  • October 28, 2013

    The second in a series of webinars by the US Women and PrEP Working Group discussed the possibilities and challenges associated with serodiscordant couples using PrEP to help them achieve pregnancy safely.

  • October 7, 2013

    AIDS Vaccine 2013 took place from October 7–10 in Barcelona, Spain. AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the best and brightest scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.

  • September 16, 2013

    The US Women and PrEP Working Group held a webinar to discuss the latest in research and rollout of PrEP for women in the US. To learn more about the US Women and PrEP Working Group (and hear about upcoming webinars), visit

  • September 12, 2013

    The seventh webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on rectal microbicides. The presentation was followed by a Q&A session.

  • September 7, 2013 to September 11, 2013

    Thousands of community leaders, front-line workers, policy makers, physicians and advocates from throughout the US met for the United States Conference on AIDS (USCA). What follows is a short list of biomedical HIV prevention research and implementation-related sessions and links to the Black Treatment Action Network/PxROAR Advocates’ Roadmap and full conference program. (The Black Treatment Action Network is a project of the Black AIDS Institute.)

  • August 6, 2013

    On June 30, the World Health Organization (WHO) released updated Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. AVAC, Global Network of People of Living with HIV (GNP+), the International HIV/AIDS Alliance (Alliance), and STOP AIDS NOW! (SAN!) held a webinar to discuss the guidelines and a new tool—Community Guide to Treatment as Prevention Programming.